18 completed, 2 terminated, 1 unknown. 11 Phase 4, 8 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 10, Terminated 1 |
| Phase 3 | 8 | Completed 6, Terminated 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Seretide: new trials by email Literature Review of Seretide trials Research Report on Seretide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation Seretide, Placebo - Stem Cell Transplant Complications, Respiratory Disease | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 35 | 2021-05-21 | 2025-09-16 |
| Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma. CMAB007, Symbicort, Seretide - Asthma, Allergic | Phase 3 | Completed | Shanghai Biomabs Pharmaceutical Co., Ltd. | 393 | 2018-05-09 | 2021-10-11 |
| Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma Salmeterol Xinafoate and Fluticasone Propinate Powder, Seretide - Asthma | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 300 | 2017-04-01 | 2018-03-12 |
| Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol Fluticasone/Formoterol, Fluticasone/Salmeterol - Asthma | Phase 4 | Terminated | Mundipharma Korea Ltd | 15 | 2015-08-31 | 2018-05-16 |
| Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) Aclidinium Bromide / Formoterol Fumarate, Salmeterol / Fluticasone - Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Completed | AstraZeneca | 933 | 2013-09-01 | 2016-03-07 |
| Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients Flutiform, Seretide, Flixotide - Asthma | Phase 3 | Completed | Mundipharma Research Limited | 498 | 2012-03-01 | 2018-10-24 |
| A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma Salmeterol/Fluticasone, Seretide - Asthma | Phase 3 | Completed | Eurofarma Laboratorios S.A. | 334 | 2011-08-01 | 2025-03-31 |
| Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis ICS+LABA, routine therapy - Bronchiectasis | Phase 4 | Completed | Shanghai Pulmonary Hospital, Shanghai, China | 120 | 2011-06-01 | 2016-05-26 |
| Comparison of Anti-inflammatory Effects of Seroflo and Seretide in Patients With Asthma Sereflo, Seretide - Asthma | Phase 3 | Completed | Mahidol University | 51 | 2011-02-01 | 2013-09-11 |
| FACTO Study (Foster® As Complete Treatment Option) FOSTER, Seretide - Asthmatic Patients | Phase 4 | Completed | Chiesi Farmaceutici S.p.A. | 431 | 2009-05-01 | 2017-03-30 |
| Real Life Effectiveness in Patients With Not Optimally Controlled Asthma Seretide - Asthma | Phase 4 | Completed | Far Eastern Memorial Hospital | 200 | 2009-03-01 | 2012-07-24 |
| Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma HFA-BDP, Fluticasone, Seretide - Asthma | Phase 4 | Completed | University of Dundee | 15 | 2009-01-01 | 2019-04-12 |
| Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler RP - TA - Asthma | Not applicable | Completed | Elpen Pharmaceutical Co. Inc. | 42 | 2008-10-01 | 2022-09-10 |
| A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) GW856553, Placebo, Seretide - Pulmonary Disease, Chronic Obstructive | Phase 2 | Completed | GlaxoSmithKline | 306 | 2008-02-14 | 2017-08-18 |
| Effect on Adrenal Function of Budesonide Versus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD) budesonide / formoterol, fluticasone/salmeterol - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | Hull University Teaching Hospitals NHS Trust | 22 | 2007-10-01 | 2010-09-06 |
| Effects on Small Airways of Two Long-term Extrafine Treatments in Asthma Salmeterol Fluticasone, formoterol - beclometasone - Bronchial Asthma | Phase 4 | Completed | Università degli Studi di Brescia | 10 | 2007-07-01 | 2010-12-07 |
| Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139) mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID, Fluticasone/Salmeterol 250/50 mcg BID - Asthma | Phase 3 | Completed | Organon and Co | 404 | 2006-06-01 | 2024-05-20 |
| Elite Sport and Development of Asthma Seretide, Placebo - Asthma | Phase 4 | Completed | Bispebjerg Hospital | 18 | 2005-09-01 | 2012-05-16 |
| SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII) Seretide, Flixotide - Asthma | Phase 4 | Completed | GlaxoSmithKline | 100 | 2005-05-03 | 2018-02-05 |
| Viapaed Study In Children And Adolescents With Asthma Salmeterol/fluticasone, Fluticasone propionate, Salbutamol - Asthma | Phase 4 | Completed | GlaxoSmithKline | 285 | 2004-11-04 | 2017-10-19 |
Showing 20 of 21. Sign in to see all of them.
Asthma (15) · Pulmonary Disease, Chronic Obstructive (3) · Bronchial Hyperreactivity (1) · Bronchiectasis (1) · Bronchiolitis Obliterans (1) · Lymphoma, Follicular (1) · Respiration Disorders (1)
GlaxoSmithKline (4) · Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · Bispebjerg Hospital (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Chiesi Farmaceutici S.p.A. (1) · Elpen Pharmaceutical Co. Inc. (1) · Eurofarma Laboratorios S.A. (1) · Far Eastern Memorial Hospital (1) · Hull University Teaching Hospitals NHS Trust (1) · Mahidol University (1) · Mundipharma Korea Ltd (1) · Mundipharma Research Limited (1) · Organon and Co (1) · Shanghai Biomabs Pharmaceutical Co., Ltd. (1)
Germany (4) · United Kingdom (4) · China (3) · France (3) · Netherlands (3) · Bulgaria (2) · Czechia (2) · Hungary (2) · Lithuania (2) · Poland (2) · Russia (2) · South Africa (2) · South Korea (2) · Spain (2) · Austria (1)
Alyn H Morice, Professor (1) · Claudio Tantucci, MD (1) · Esther Garcia, Ph.D. (1) · Jin-Fu Xu (1) · Kittipong Maneechotesuwan, MD., PhD. (1) · Nanshan Zhong, M.D. (1) · Neil Barnes, MD (1) · Peter A Williamson (1) · Thomas Lund, MD (1)
PMID 36472162, PMID 15741443, PMID 20874458, PMID 21778259, PMID 22221427, PMID 22568828, PMID 23524015, PMID 24913725, PMID 25044280, PMID 27492833, PMID 41345745
2008 (2)